BACKGROUND: The association between hyperuricemia and incident heart failure (HF) is relatively unknown. METHODS: Of the 5461 community-dwelling older adults, >or=65 years, in the Cardiovascular Health Study without HF at baseline, 1505 had hyperuricemia (baseline serum uric acid >or=6 mg/dL for women and >or=7 mg/dL for men). Using propensity scores for hyperuricemia, estimated for each participant using 64 baseline covariates, we were able to match 1181 pairs of participants with and without hyperuricemia. RESULTS: Incident HF occurred in 21% and 18% of participants respectively with and without hyperuricemia during 8.1 years of mean follow-up (hazard ratio {HR} for hyperuricemia versus no hyperuricemia, 1.30; 95% confidence interval {CI}, 1.05-1.60; P=0.015). The association between hyperuricemia and incident HF was significant only in subgroups with normal kidney function (HR, 1.23; 95% CI, 1.02-1.49; P=0.031), without hypertension (HR, 1.31; 95% CI, 1.03-1.66; P=0.030), not receiving thiazide diuretics (HR, 1.20; 95% CI, 1.01-1.42; P=0.044), and without hyperinsulinemia (HR, 1.35; 95% CI, 1.06-1.72; P=0.013). Used as a continuous variable, each 1 mg/dL increase in serum uric acid was associated with a 12% increase in incident HF (HR, 1.12; 95% CI, 1.03-1.22; P=0.006). Hyperuricemia had no association with acute myocardial infarction or all-cause mortality. CONCLUSIONS: Hyperuricemia is associated with incident HF in community-dwelling older adults. Cumulative data from our subgroup analyses suggest that this association is only significant when hyperuricemia is a marker of increased xanthine oxidase activity but not when hyperuricemia is caused by impaired renal elimination of uric acid. Published by Elsevier Ireland Ltd.
BACKGROUND: The association between hyperuricemia and incident heart failure (HF) is relatively unknown. METHODS: Of the 5461 community-dwelling older adults, >or=65 years, in the Cardiovascular Health Study without HF at baseline, 1505 had hyperuricemia (baseline serum uric acid >or=6 mg/dL for women and >or=7 mg/dL for men). Using propensity scores for hyperuricemia, estimated for each participant using 64 baseline covariates, we were able to match 1181 pairs of participants with and without hyperuricemia. RESULTS: Incident HF occurred in 21% and 18% of participants respectively with and without hyperuricemia during 8.1 years of mean follow-up (hazard ratio {HR} for hyperuricemia versus no hyperuricemia, 1.30; 95% confidence interval {CI}, 1.05-1.60; P=0.015). The association between hyperuricemia and incident HF was significant only in subgroups with normal kidney function (HR, 1.23; 95% CI, 1.02-1.49; P=0.031), without hypertension (HR, 1.31; 95% CI, 1.03-1.66; P=0.030), not receiving thiazide diuretics (HR, 1.20; 95% CI, 1.01-1.42; P=0.044), and without hyperinsulinemia (HR, 1.35; 95% CI, 1.06-1.72; P=0.013). Used as a continuous variable, each 1 mg/dL increase in serum uric acid was associated with a 12% increase in incident HF (HR, 1.12; 95% CI, 1.03-1.22; P=0.006). Hyperuricemia had no association with acute myocardial infarction or all-cause mortality. CONCLUSIONS:Hyperuricemia is associated with incident HF in community-dwelling older adults. Cumulative data from our subgroup analyses suggest that this association is only significant when hyperuricemia is a marker of increased xanthine oxidase activity but not when hyperuricemia is caused by impaired renal elimination of uric acid. Published by Elsevier Ireland Ltd.
Authors: Gina D Schellenbaum; Thomas D Rea; Susan R Heckbert; Nicholas L Smith; Thomas Lumley; Veronique L Roger; Dalane W Kitzman; Herman A Taylor; Daniel Levy; Bruce M Psaty Journal: Am J Epidemiol Date: 2004-10-01 Impact factor: 4.897
Authors: Ali Ahmed; Inmaculada B Aban; Viola Vaccarino; Donald M Lloyd-Jones; David C Goff; Jiannan Zhao; Thomas E Love; Christine Ritchie; Fernando Ovalle; Giovanni Gambassi; Louis J Dell'Italia Journal: Heart Date: 2007-05-08 Impact factor: 5.994
Authors: D E Chambers; D A Parks; G Patterson; R Roy; J M McCord; S Yoshida; L F Parmley; J M Downey Journal: J Mol Cell Cardiol Date: 1985-02 Impact factor: 5.000
Authors: John Kanellis; Susumu Watanabe; Jin H Li; Duk Hee Kang; Ping Li; Takahiko Nakagawa; Ann Wamsley; David Sheikh-Hamad; Hui Y Lan; Lili Feng; Richard J Johnson Journal: Hypertension Date: 2003-05-12 Impact factor: 10.190
Authors: E Ferrannini; G Buzzigoli; R Bonadonna; M A Giorico; M Oleggini; L Graziadei; R Pedrinelli; L Brandi; S Bevilacqua Journal: N Engl J Med Date: 1987-08-06 Impact factor: 91.245
Authors: Ali Ahmed; Faiez Zannad; Thomas E Love; Jose Tallaj; Mihai Gheorghiade; Olaniyi James Ekundayo; Bertram Pitt Journal: Eur Heart J Date: 2007-06 Impact factor: 29.983
Authors: Ravi V Desai; Mustafa I Ahmed; Gregg C Fonarow; Gerasimos S Filippatos; Michel White; Inmaculada B Aban; Wilbert S Aronow; Ali Ahmed Journal: Am J Cardiol Date: 2010-10-15 Impact factor: 2.778
Authors: Anand S Iyer; Mustafa I Ahmed; Gerasimos S Filippatos; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Navin C Nanda; George L Bakris; Gregg C Fonarow; Wilbert S Aronow; Ali Ahmed Journal: J Am Soc Hypertens Date: 2010 Jan-Feb
Authors: Marjan Mujib; Abu-Ahmed Z Rahman; Ravi V Desai; Mustafa I Ahmed; Margaret A Feller; Inmaculada Aban; Thomas E Love; Michel White; Prakash Deedwania; Wilbert S Aronow; Gregg Fonarow; Ali Ahmed Journal: Am J Cardiol Date: 2010-12-22 Impact factor: 2.778
Authors: C Barrett Bowling; Margaret A Feller; Marjan Mujib; Pushkar P Pawar; Yan Zhang; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Paul W Sanders; Stefan D Anker; Gregg C Fonarow; Ali Ahmed Journal: Am J Nephrol Date: 2011-07-04 Impact factor: 3.754
Authors: S Jain; T G Ton; R M Boudreau; M Yang; E L Thacker; S Studenski; W T Longstreth; E S Strotmeyer; A B Newman Journal: Neuroepidemiology Date: 2011-06-16 Impact factor: 3.282
Authors: Kanan Patel; Xuemei Sui; Yan Zhang; Gregg C Fonarow; Inmaculada B Aban; Cynthia J Brown; Vera Bittner; Dalane W Kitzman; Richard M Allman; Maciej Banach; Wilbert S Aronow; Stefan D Anker; Steven N Blair; Ali Ahmed Journal: Int J Cardiol Date: 2013-02-04 Impact factor: 4.164
Authors: Beth M Cleveland; Stephen S Leonard; Hillar Klandorf; Kenneth P Blemings Journal: Oxid Med Cell Longev Date: 2009 Apr-Jun Impact factor: 6.543
Authors: Mustafa I Ahmed; Mitja Lainscak; Marjan Mujib; Thomas E Love; Inmaculada Aban; Ileana L Piña; Wilbert S Aronow; Vera Bittner; Ali Ahmed Journal: Int J Cardiol Date: 2009-11-24 Impact factor: 4.164